cladribine has been researched along with Leukemia, Lymphocytic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bojarska-Junak, A; Chocholska, S; Dmoszynska, A; Klimek, P; Kowal, M; Podhorecka, M | 1 |
| Bontemps, F; Cardoen, S; Offner, F; Van den Neste, E | 1 |
| Carson, DA; Wasson, DB; Yu, A | 1 |
| Edelman, MJ; Meadows, I; O'Donnell, RT | 1 |
| Hotta, T; Kinoshita, T; Kobayashi, Y; Kozuru, M; Narabayashi, M; Ogura, M; Ohashi, Y; Suzuki, R; Tobinai, K; Uike, N | 1 |
| Aleskog, A; Höglund, M; Kristensen, J; Larsson, R; Sundström, C | 1 |
| Itälä, M; Remes, K | 1 |
| Blakley, RL; Griffig, J; Koob, R | 1 |
| Beutler, E; Carrera, CJ; Carson, DA; Piro, LD | 1 |
2 review(s) available for cladribine and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle; Cell Membrane; Cell Proliferation; Cell Survival; Cladribine; DNA; DNA Damage; DNA Repair; DNA-Directed DNA Polymerase; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Models, Biological; Models, Chemical; Nucleosides; RNA; Signal Transduction; Tumor Suppressor Protein p53; Vidarabine | 2005 |
[Nucleoside analogues--new drugs for the treatment of lymphatic cancers].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Leukemia, Lymphoid; Lymphoma; Nucleosides; Pentostatin; Vidarabine | 2001 |
1 trial(s) available for cladribine and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
Topics: Aged; Antineoplastic Agents; Cladribine; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1997 |
6 other study(ies) available for cladribine and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression.
Topics: ADP-ribosyl Cyclase 1; Antineoplastic Agents; Apoptosis; B-Lymphocyte Subsets; bcl-2-Associated X Protein; Biomarkers; Bone Marrow Cells; Caspase 3; Chronic Disease; Cladribine; Disease Progression; Enzyme Activation; Humans; Leukemia, Lymphoid; Membrane Glycoproteins; Prognosis; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Vidarabine; ZAP-70 Protein-Tyrosine Kinase | 2010 |
Cell cycle independent lymphocytotoxicity of 2-chlorodeoxyadenosine.
Topics: Animals; Cell Cycle; Cell Line; Cell Survival; Cladribine; Deoxyadenosines; Deoxycytidine; Humans; Leukemia, Lymphoid; Lymphocytes; Mice; Purine Nucleosides; Structure-Activity Relationship | 1984 |
Treatment of refractory large granular lymphocytic leukemia with 2-chlorodeoxyadenosine.
Topics: Antineoplastic Agents; Cladribine; Gene Rearrangement; Humans; Leukemia, Lymphoid; Male; Middle Aged; Receptors, Antigen, T-Cell | 1997 |
Evaluation of purine and pyrimidine analogues in human tumor cells from patients with low-grade lymphoproliferative disorders using the FMCA.
Topics: Acute Disease; Antineoplastic Agents; Cladribine; Cytarabine; Fluorescence; Fluorometry; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Survival Analysis; Vidarabine | 1999 |
Mechanisms of inhibition of DNA synthesis by 2-chlorodeoxyadenosine in human lymphoblastic cells.
Topics: 2-Chloroadenosine; Chromatography, High Pressure Liquid; Cladribine; Deoxyadenosines; DNA Replication; DNA, Neoplasm; Humans; Leukemia, Lymphoid; Ribonucleotides; Tumor Cells, Cultured | 1989 |
2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia.
Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Cladribine; Deoxyadenosines; Female; Humans; Leukemia, Lymphoid; Male; Middle Aged; Remission Induction; Tumor Cells, Cultured | 1988 |